Providers report benefits partnering with population health vendors

Laura Pedulli | | Health Exec | Economics

The population health market is seeing some satisfied customers. Seventy percent of providers report tangible benefits to patient care when using certain population health vendors, according to a report published by KLAS, a global research firm.   

KLAS interviewed 203 providers at 173 organizations to determine which vendors are effectively driving outcomes and where the needle is when it comes to providing better patient care and reducing costs. The vendors assessed include the Advisory Board, Alere, Allscripts, athenahealth, Caradigm, Cerner, Conifer Health Solutions, eClinicalWorks, Epic, Evolent, Explorys, Forward Health Group, Healthagen, Health Catalyst, i2i Systems, Kryptiq, Lumeris, McKesson, Medecision, NextGen Healthcare, Optum, Phytel, Premier, Siemens, Valence, Verisk Health, Wellcentive and xG Health.

"Providers are starting to recognize the tangible benefits of population health efforts," said report author Mark Allphin in a statement. With all of the focus on this segment, providers are asking which vendors are best positioned to help them realize those benefits. This report was an effort to answer that question."

Access the report. 

Laura Pedulli

Related Content

Merck spends up to $2B to license new weight loss drug with potential heart benefits
Insulet wins $452M in lawsuit against rivals over medical device trade secrets
Medical device company cuts 70% of staff in push to meet Medtronic obligations
Cleerly’s momentum continues as AI specialists raise $106M
Operations manager, doctors charged in $70M imaging kickback scheme
Private-equity watchdog warns against nominating Marc Rowan as Treasury Secretary

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.